CN113144102A - Novel eye drop for improving eyesight and resisting fatigue - Google Patents

Novel eye drop for improving eyesight and resisting fatigue Download PDF

Info

Publication number
CN113144102A
CN113144102A CN202110288310.8A CN202110288310A CN113144102A CN 113144102 A CN113144102 A CN 113144102A CN 202110288310 A CN202110288310 A CN 202110288310A CN 113144102 A CN113144102 A CN 113144102A
Authority
CN
China
Prior art keywords
eye drop
liquid
improving eyesight
resisting fatigue
fatigue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110288310.8A
Other languages
Chinese (zh)
Inventor
阿力木扎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Limuzha
Original Assignee
A Limuzha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Limuzha filed Critical A Limuzha
Priority to CN202110288310.8A priority Critical patent/CN113144102A/en
Publication of CN113144102A publication Critical patent/CN113144102A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/24Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles
    • A61K35/583Snakes; Lizards, e.g. chameleons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/56Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/68Plantaginaceae (Plantain Family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • A61K36/8984Dendrobium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Insects & Arthropods (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a novel eyesight-improving and fatigue-resisting eye drop, and relates to the technical field of eye drops. The novel eyesight-improving and fatigue-resisting eye drop comprises the following components in parts by weight: 2-3g of chrysanthemum, 1-3g of medlar, 1-2g of spreading hedyotis herb, 2-3g of honeysuckle, 1-2g of mulberry leaf, 1-3g of scouring rush, 2-3g of pipewort, 1-2g of butterflybush flower, 2-4g of coptis root, 3-5g of cassia seed, 1-3g of scutellaria baicalensis, 1g of cicada slough, 1-2g of ash bark, 2-4g of feather cockscomb seed, 0.5-1g of bat dung, 1-3g of snake slough, 0.5-1g of calamine, 1-2g of snake gall, 2-3g of dendrobium, 1-3g of prepared rhizome of rehmannia, 3-6g of plantain seed and distilled water. The eye drop designed by the invention can effectively treat diseases caused by various inflammations, and can treat ametropia such as myopia, hyperopia, astigmatism, yellow spot and the like, and the eye drop does not contain any additive and is safe to use.

Description

Novel eye drop for improving eyesight and resisting fatigue
Technical Field
The invention relates to the technical field of eye drops, in particular to a novel eyesight-improving and fatigue-resisting eye drop.
Background
The eye diseases are increasing and not neglected. As a result of national teenager physique and health investigation in 2014, myopia continues to rise in all stages in China, and according to the 'vision health report' issued by Beijing university in the same period, if effective policy intervention does not exist, the number of eye disease patients is estimated to reach 7 hundred million in 2020, wherein 5000 million people with high myopia are expected, and the problem of eye disease is very difficult.
Various eye drops have appeared in the market at present, and the eye drops have different functions, or are used for eliminating inflammation, or eliminating eye swelling and fatigue and the like, but the actual using effects of the eye drops are very common, and the eye drops treat the vision problems of users, so that a novel eye drop for improving eyesight and resisting fatigue is needed to be designed.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides a novel eyesight-improving and fatigue-resisting eye drop, and solves the problem that the existing eye drop has common efficacy and cannot effectively relieve the eyesight of a user.
(II) technical scheme
In order to achieve the purpose, the invention is realized by the following technical scheme: a novel eyesight-improving and fatigue-resisting eye drop comprises the following components in parts by weight: 2-3g of chrysanthemum, 1-3g of medlar, 1-2g of spreading hedyotis herb, 2-3g of honeysuckle, 1-2g of mulberry leaf, 1-3g of scouring rush, 2-3g of pipewort, 1-2g of butterflybush flower, 2-4g of coptis root, 3-5g of cassia seed, 1-3g of scutellaria baicalensis, 1g of cicada slough, 1-2g of ash bark, 2-4g of feather cockscomb seed, 0.5-1g of bat dung, 1-3g of snake slough, 0.5-1g of calamine, 1-2g of snake gall, 2-3g of dendrobium, 1-3g of prepared rhizome of rehmannia, 3-6g of plantain seed and distilled water.
Preferably, the preparation process of the novel eyesight-improving and fatigue-resisting eye drop comprises the following steps:
s1, preparing all raw materials, and sterilizing and disinfecting the raw materials;
s2, respectively grinding chrysanthemum, oldenlandia diffusa, honeysuckle, mulberry leaves, scouring rush, pipewort and butterflybush flower, and collecting juice;
s3, grinding semen cassiae, cicada slough, feather cockscomb seed, bat dung, snake slough, calamine, snake gall, dendrobium, poria cocos and semen plantaginis into powder, then putting the powder into a container, adding distilled water to soak for 1-2 hours, then heating and boiling, extracting liquid medicine, and filtering to obtain filtrate;
s4, slicing the coptis chinensis, the scutellaria baicalensis, the ash bark and the prepared rehmannia root, putting the tablets into a container, adding distilled water to soak for 2-3h, heating and cooking for 6-7h, collecting upper-layer liquid medicine in the container after cooking is finished, and treating collected liquid to obtain standard liquid medicine;
s5, putting the liquid medicines prepared in the steps S2, S3 and S4 into the same container, mixing and stirring, and then adjusting the pH value of the liquid medicine to be 6.8-7.2;
s6, bottling the prepared liquid medicine.
Preferably, the medicinal material in the S3 is crushed to 200 meshes and 250 meshes.
Preferably, the detailed processing steps of the S3 traditional Chinese medicine powder are as follows: after the medicinal powder is soaked, adding 2L of distilled water, heating and boiling for 3-4h, and extracting medicinal liquid; adding 1L distilled water, heating and boiling for 5-6 hr to obtain medicinal liquid; mixing the two extractive solutions, precipitating for 4-6 hr, and filtering to obtain the medicinal solution.
Preferably, the subsequent treatment process of the collected liquid in S4 is as follows: and (3) putting the collected liquid into a container, stirring and mixing, then filtering the stirred collected liquid for 2 times, then precipitating the filtered collected liquid for 2-3 hours, and collecting the liquid with the thickness of one third of the collected liquid in the container to obtain the standby liquid medicine.
Preferably, the stirring rate of the collected liquid in the subsequent treatment of the collected liquid in the S4 is controlled to be 30-50r/min, and the stirring is carried out for 10-20 min.
Preferably, the stirring speed in the S5 is controlled to be 60-80r/min, and the stirring time is controlled to be 4-5 h.
Preferably, the raw material sterilization in S1 is performed by a moist heat sterilization method.
The chrysanthemum, which can calm down liver yang, clear liver and improve vision, and clear heat and detoxify, not only can make people clear head and eyes bright, but also can have better curative effect on dry eyes caused by hyperactivity of liver fire, overuse of eyes and the like;
the medlar can clear heat and improve eyesight;
oldenlandia diffusa with good anti-inflammatory function;
the mulberry leaf has the health care and health preservation effects of dispelling wind and heat, clearing lung and moistening dryness, clearing liver and improving vision and the like;
the honeysuckle has broad-spectrum antibacterial, heat-clearing and detoxifying, disease-removing and health-preserving effects, and can treat symptoms such as cold, headache, conjunctival congestion, deafness and the like;
scouring rush has effects of dispelling wind and heat, improving eyesight, removing nebula, stopping bleeding;
flos Eriocauli has effects of dispelling pathogenic wind heat, improving eyesight and removing nebula, and can be used for treating wind heat of liver channel, conjunctival congestion and swelling pain, nebula, headache due to wind heat, and nyctalopia;
flos Buddlejae has effects of dispelling pathogenic wind, cooling blood, moistening liver, and improving eyesight, and can be used for treating conjunctival congestion, swelling and pain, lacrimation, photophobia, cataract, and erosion of eye due to pathogenic wind;
coptis root, damp-heat and fullness, insomnia, palpitation, red eyes, toothache, diabetes, carbuncle and swelling and sore treatment;
semen Cassiae for treating conjunctival congestion, photophobia, lacrimation, headache, vertigo, and dim eyesight;
scutellariae radix for treating conjunctival congestion with swelling and pain;
periostracum Cicadae for removing nebula and improving eyesight;
cortex Fraxini for treating conjunctival congestion, swelling and pain, and nebula;
the feather cockscomb seed has the effects of clearing liver fire, dispelling wind heat and improving eyesight;
night-vision sand used for the treatment of blindness, bromhidrosis, conjunctival congestion, swelling and pain, leucorrhea with bloody discharge, nebula and cataract;
snake slough has the efficacies of improving eyesight and removing nebula;
calamine is used for treating red, swollen and painful eyes, red rot of eye margin and pterygium of corneal macula;
periostracum Serpentis, Galamina, fel Serpentis, herba Dendrobii, radix rehmanniae Preparata, and semen plantaginis have effects of improving eyesight and removing nebula.
(III) advantageous effects
The invention provides a novel eye drop for improving eyesight and resisting fatigue. The method has the following beneficial effects:
the raw materials of the eye drop designed by the invention contain a plurality of different eyesight-improving and inflammation-diminishing traditional Chinese medicines, and the useful substances in various medicinal materials are extracted by a design method, so that the eye drop has the effects of diminishing inflammation and improving eyesight, can treat diseases caused by various inflammations, such as inflammation of eyelids, inflammation of eyelid margin, conjunctivitis, keratitis, iridocyclitis, uveitis, cataract and the like, and can also effectively treat ametropia, such as myopia, hypermetropia, astigmatism, yellow spots and the like, and fully protect the eyes of a user.
The eye drop designed by the invention has no additive added in the raw materials, and the eye drop has no side effect and is absolutely safe and stable when in use through test investigation.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
the embodiment of the invention provides a novel eyesight-improving and fatigue-resisting eye drop, which comprises the following components in parts by weight: 2g of chrysanthemum, 2g of medlar, 2g of spreading hedyotis herb, 2g of honeysuckle, 1g of mulberry leaf, 2g of scouring rush, 2g of pipewort, 1g of pale butterflybush flower, 2g of coptis root, 3g of cassia seed, 1g of scutellaria baicalensis, 1g of periostracum cicadae, 1g of ash bark, 2g of feather cockscomb seed, 0.5g of bat dung, 1g of snake slough, 0.5g of calamine, 1g of snake gall, 2g of dendrobium, 1g of prepared rhizome of rehmannia, 5g of plantain seed and distilled water.
The preparation process of the novel eyesight-improving and fatigue-resisting eye drop comprises the following steps:
s1, preparing all raw materials, and sterilizing and disinfecting the raw materials;
s2, respectively grinding chrysanthemum, oldenlandia diffusa, honeysuckle, mulberry leaves, scouring rush, pipewort and butterflybush flower, and collecting juice;
s3, grinding semen cassiae, cicada slough, feather cockscomb seed, bat dung, snake slough, calamine, snake gall, dendrobium and plantain seed into powder, putting the powder into a container, adding distilled water to soak for 1.5 hours, heating and boiling, extracting liquid medicine, and filtering to obtain filtrate;
s4, slicing the coptis chinensis, the scutellaria baicalensis, the ash bark and the prepared rhizome of rehmannia, putting the tablets into a container, adding distilled water to soak for 2 hours, heating and cooking for 6 hours, collecting upper-layer liquid medicine in the container after cooking is finished, and treating collected liquid to obtain standard liquid medicine;
s5, putting the liquid medicines prepared in the steps S2, S3 and S4 into the same container, mixing and stirring, and then adjusting the pH value of the liquid medicine to be 6.9;
s6, bottling the prepared liquid medicine.
Example two:
the embodiment of the invention provides a novel eyesight-improving and fatigue-resisting eye drop, which comprises the following components in parts by weight: 3g of chrysanthemum, 2g of medlar, 1g of spreading hedyotis herb, 2g of honeysuckle, 2g of mulberry leaf, 2g of scouring rush, 2g of pipewort, 1g of pale butterflybush flower, 3g of coptis root, 4g of cassia seed, 1g of scutellaria baicalensis, 1g of periostracum cicadae, 2g of ash bark, 2g of feather cockscomb seed, 0.5g of bat dung, 1g of snake slough, 0.5g of calamine, 1g of snake gall, 2g of dendrobium, 1g of prepared rhizome of rehmannia, 3g of plantain seed and distilled water.
Example three:
the embodiment of the invention provides a novel eyesight-improving and fatigue-resisting eye drop, which comprises the following components in parts by weight: 2g of chrysanthemum, 2g of medlar, 2g of spreading hedyotis herb, 2g of honeysuckle, 1g of mulberry leaf, 2g of scouring rush, 2g of pipewort, 1g of pale butterflybush flower, 2g of coptis root, 4g of cassia seed, 2g of scutellaria baicalensis, 1g of cicada slough, 1g of ash bark, 2g of feather cockscomb seed, 1g of bat dung, 1g of snake slough, 1g of calamine, 2g of snake gall, 2g of dendrobium, 2g of prepared rhizome of rehmannia, 5g of plantain seed and distilled water.
Example four:
the embodiment of the invention provides a novel eyesight-improving and fatigue-resisting eye drop, which comprises the following components in parts by weight: 3g of chrysanthemum, 3g of medlar, 1g of spreading hedyotis herb, 3g of honeysuckle, 2g of mulberry leaf, 2g of scouring rush, 2g of pipewort, 1g of pale butterflybush flower, 2g of coptis root, 3g of cassia seed, 1g of scutellaria baicalensis, 1g of periostracum cicadae, 1g of ash bark, 2g of feather cockscomb seed, 1g of bat dung, 1g of snake slough, 0.5g of calamine, 1g of snake gall, 2g of dendrobium, 1g of prepared rhizome of rehmannia, 3g of plantain seed and distilled water.
Four groups of eye drops are prepared according to the formula provided by the four embodiments and are respectively named as an experiment group I, an experiment group II, an experiment group III and an experiment group IV, 40 mild myopia patients and 10 mild myopia patients are selected and divided into four groups, the four groups of eye drops are respectively tried by four groups of people for one month, and then the eye drops are investigated and evaluated to obtain the following results:
Figure RE-GSB0000193795160000051
Figure RE-GSB0000193795160000061
from the above data, it can be seen that the eye drop has an effect of treating visual problems without side effects.
40 experimenters with different inflammations on eyes are selected, 10 experimenters are divided into four groups, four groups of the experimenters respectively try four groups of eye drops for one month, and then the investigation and evaluation result is that:
Figure RE-GSB0000193795160000062
from the above data, it can be seen that the ophthalmic solution has an excellent effect of treating ocular inflammation.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (8)

1. A novel eye drop for improving eyesight and resisting fatigue is characterized in that: the eyedrop comprises the following components in parts by weight: 2-3g of chrysanthemum, 1-3g of fructus lycii, 1-2g of oldenlandia diffusa, 2-3g of honeysuckle, 1-2g of mulberry leaf, 1-3g of scouring rush, 2-3g of pipewort, 1-2g of butterflybush flower, 2-4g of coptis chinensis, 3-5g of cassia seed, 1-3g of scutellaria baicalensis, 1g of periostracum cicada, 1-2g of ash bark, 2-4g of feather cockscomb seed, 0.5-1g of bat dung, 1-3g of snake slough, 0.5-1g of calamine, 1-2g of snake gall, 2-3g of dendrobium, 1-3g of prepared rhizome of rehmannia, 3-6g of plantain seed and distilled water.
2. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 1, wherein: the preparation process of the novel eyesight-improving and fatigue-resisting eye drop comprises the following steps:
s1, preparing all raw materials, and sterilizing and disinfecting the raw materials;
s2, respectively grinding chrysanthemum, oldenlandia diffusa, honeysuckle, mulberry leaves, scouring rush, pipewort and butterflybush flower, and collecting juice;
s3, grinding semen cassiae, cicada slough, feather cockscomb seed, bat dung, snake slough, calamine, snake gall, dendrobium and semen plantaginis into powder, then putting the powder into a container, adding distilled water to soak for 1-2 hours, then heating and boiling, extracting liquid medicine, and filtering to obtain filtrate;
s4, slicing the coptis chinensis, the scutellaria baicalensis, the ash bark and the prepared rehmannia root, putting the tablets into a container, adding distilled water to soak for 2-3h, heating and cooking for 6-7h, collecting upper-layer liquid medicine in the container after cooking is finished, and treating collected liquid to obtain standard liquid medicine;
s5, putting the liquid medicines prepared in the steps S2, S3 and S4 into the same container, mixing and stirring, and then adjusting the pH value of the liquid medicine to be 6.8-7.2;
s6, bottling the prepared liquid medicine.
3. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 2, wherein: the raw materials of the medicinal materials in the S3 are crushed into 200 meshes and 250 meshes.
4. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 2, wherein: the detailed processing steps of the S3 traditional Chinese medicine powder are as follows: after the medicinal powder is soaked, adding 2L of distilled water, heating and boiling for 3-4h, and extracting medicinal liquid; adding 1L distilled water, heating and boiling for 5-6 hr to obtain medicinal liquid; mixing the two extractive solutions, precipitating for 4-6 hr, and filtering to obtain the medicinal solution.
5. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 2, wherein: the subsequent treatment process of the collected liquid in the step S4 is as follows: and (3) putting the collected liquid into a container, stirring and mixing, then filtering the stirred collected liquid for 2 times, then precipitating the filtered collected liquid for 2-3 hours, and collecting the liquid with the thickness of one third of the collected liquid in the container to obtain the standby liquid medicine.
6. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 5, wherein: and the stirring speed of the collected liquid in the subsequent treatment of the collected liquid in the S4 is controlled to be 30-50r/min, and the stirring is carried out for 10-20 min.
7. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 2, wherein: in the S5, the stirring speed is controlled to be 60-80r/min, and the stirring time is controlled to be 4-5 h.
8. The novel eye drop for improving eyesight and resisting fatigue as claimed in claim 2, wherein: and the raw material in the S1 is sterilized by a moist heat sterilization method.
CN202110288310.8A 2021-03-11 2021-03-11 Novel eye drop for improving eyesight and resisting fatigue Pending CN113144102A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110288310.8A CN113144102A (en) 2021-03-11 2021-03-11 Novel eye drop for improving eyesight and resisting fatigue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110288310.8A CN113144102A (en) 2021-03-11 2021-03-11 Novel eye drop for improving eyesight and resisting fatigue

Publications (1)

Publication Number Publication Date
CN113144102A true CN113144102A (en) 2021-07-23

Family

ID=76887535

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110288310.8A Pending CN113144102A (en) 2021-03-11 2021-03-11 Novel eye drop for improving eyesight and resisting fatigue

Country Status (1)

Country Link
CN (1) CN113144102A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114028478A (en) * 2021-11-02 2022-02-11 张红伟 Traditional Chinese medicine eye ointment for treating myopia

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115655A (en) * 1994-07-29 1996-01-31 谢锷 Health liquid of snake bile
CN101897370A (en) * 2010-07-02 2010-12-01 黄毅 Eyesight-improving health protection tea
CN104027651A (en) * 2014-06-27 2014-09-10 郑增友 Eye drops for treating eye diseases
CN106860699A (en) * 2017-02-23 2017-06-20 张红伟 A kind of Chinese medicine eye ointment for treating presbyopic illness in eye
CN112891439A (en) * 2019-11-18 2021-06-04 惠州市华达生物科技有限公司 Compound pipewort liquid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115655A (en) * 1994-07-29 1996-01-31 谢锷 Health liquid of snake bile
CN101897370A (en) * 2010-07-02 2010-12-01 黄毅 Eyesight-improving health protection tea
CN104027651A (en) * 2014-06-27 2014-09-10 郑增友 Eye drops for treating eye diseases
CN106860699A (en) * 2017-02-23 2017-06-20 张红伟 A kind of Chinese medicine eye ointment for treating presbyopic illness in eye
CN112891439A (en) * 2019-11-18 2021-06-04 惠州市华达生物科技有限公司 Compound pipewort liquid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114028478A (en) * 2021-11-02 2022-02-11 张红伟 Traditional Chinese medicine eye ointment for treating myopia

Similar Documents

Publication Publication Date Title
CN101732506B (en) External oculentum for treating amblyopia, astigmatism, strabismus, myopia and visual fatigue of teenagers
CN101185700B (en) Medicine for treating cataract
CN102631558B (en) Medicament for treating eye disease and preparation method of medicament
CN109528500A (en) A kind of eye sticker composition and preparation method thereof
CN109350588A (en) A kind of easily absorption, anti-aging, anti-radiation ophthalmic composition and preparation method thereof
CN113144102A (en) Novel eye drop for improving eyesight and resisting fatigue
CN109700889A (en) A kind of Chinese medicine composition and preparation method thereof of health care eyes
CN102198227B (en) Method for preparing Chinese medicine for treating yin-deficiency glaucoma
CN115006336A (en) Plant shampoo capable of preventing hair loss, strengthening hair, removing dandruff and relieving itching and preparation method thereof
CN108653429A (en) A kind of Chinese medicine composition that treating sty disease and its application
CN113663026A (en) Traditional Chinese medicine eye-protecting liquid and preparation method thereof
CN103751500A (en) Chinese herbal medicine granule for treating cataract and preparation method thereof
CN103860736B (en) One treats cataractous Chinese medicine preparation and preparation method
CN112076268A (en) Traditional Chinese medicine lotion for preventing and treating alopecia and blackening hair, preparation method and application
CN113925910B (en) A topical Chinese medicinal composition for treating myopia, and its preparation method
CN110624086A (en) Traditional Chinese medicine composition beneficial to improving eyesight and preparation method thereof
CN116211984B (en) A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method
CN1251744C (en) Chinese medicinal pill and eye drops for treating myopia, and preparing process thereof
CN105920360A (en) Pharmaceutical composition containing radix paeoniae alba and fruit of Chinese wolfberry for preventing and treating eye diseases
CN103520610B (en) Traditional Chinese medicine composition for relieving asthenopia and preparation method thereof
CN112206280B (en) Health tea with effects of clearing liver and moistening eyes and preparation method thereof
CN115089633B (en) Composition for preventing and treating myopia, eye mask and preparation method
CN106491730A (en) A kind of treat Chinese medicine composition of glaucoma and preparation method thereof
CN110742992A (en) A Chinese medicinal composition for external use for treating eyesight, and its preparation method
CN105641255A (en) Eye drops capable of diminishing inflammation, inducing resuscitation and improving eyesight and preparation method of eye drops

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210723

RJ01 Rejection of invention patent application after publication